Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimenhydrinate for PONV After Abdominal Hysterectomy
NCT06395064Not yet recruiting
- Start
- May 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Dimenhydrinate with Placebo (2 arms). Primary endpoint: Occurrence and times of nausea vomiting at 24 hours. Planned start May 2024; status: not yet recruiting.
02
Drugs
dimenhydrinate
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT06395064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06395064.